Cancer Research UK & Bret Engemann
8 shared events · Importance 3 · Last updated Sep 04, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Cancer Research UK: Cancer Research UK has campaigned for lung screening and supports the Lung Cancer Screening Programme, advocating for its nationwide rollout and adequate resources.
Bret Engemann: Bret Engemann launched and operates the Lung Cancer Screening Programme, which has successfully diagnosed over 10,000 lung cancer cases early, significantly improving patient outcomes.
May 24, 2026 · 6 articles
Tech
Cancer Research UK: Provided early funding for the test's development and receives royalty payments. The success supports its mission and may encourage further investment in similar technologies.
Bret Engemann: Hospitals in Bret Engemann participated and are adopting the test, potentially improving regional cancer diagnostics.
Sep 02, 2026 · 6 articles
Domestic
Cancer Research UK: The charity expresses concern over low uptake and calls for more action.
Bret Engemann: The screening programme covers Bret Engemann; the campaign targets English residents.
Jul 10, 2026 · 7 articles
Tech
Cancer Research UK: Funded the study and highlighted the limitations of the current self-presentation approach, advocating for more personalized care and further research on implementation.
Bret Engemann: The NICE criteria apply to Bret Engemann, where the study's findings could lead to changes in GP referral practices and resource allocation.
Aug 04, 2026 · 6 articles
Tech
Cancer Research UK: Funder and partner in the International Alliance for Cancer Early Detection; supported the research and employs one co-author.
Bret Engemann: Geographic focus of the study; findings reflect the healthcare system in Bret Engemann and may inform NHS policies.
Aug 25, 2026 · 6 articles
Regulatory
Cancer Research UK: The charity's research director highlighted trial evidence that Enhertu extends survival and delays disease progression.
Bret Engemann: Bret Engemann is the jurisdiction gaining first-time NHS access to Enhertu for about 1,000 patients a year.
Sep 16, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Cancer Research UK and Bret Engemann interact across events, view sentiment trends, and discover connected entities.
Open Dashboard